Defining a standard set of patient-centered outcomes for men with localized prostate cancer

European Urology

Volumn 67, Issue 3, 2015, Pages 460-467

  Martin, Neil E ^a,b   Massey, Laura ^a   Stowell, Caleb ^a   Bangma, Chris ^c   Briganti, Alberto ^d   Bill Axelson, Anna ^e   Blute, Michael ^f   Catto, James ^g   Chen, Ronald C ^h   D'Amico, Anthony V ^b   Feick, Günter ⁱ   Fitzpatrick, John M ^j   Frank, Steven J ^k   Froehner, Michael ^l   Frydenberg, Mark ^m   Glaser, Adam ⁿ   Graefen, Markus ^o   Hamstra, Daniel ^p   Kibel, Adam ^q   Mendenhall, Nancy ^r   Moretti, Kim ^s   Ramon, Jacob ^t   Roos, Ian ^u   Sandler, Howard ^v   Sullivan, Francis J ^w   Swanson, David ^k   Tewari, Ashutosh ^x   Vickers, Andrew ^y   Wiegel, Thomas ^z   Huland, Hartwig ^o   more..

^a International Consortium for Health Outcomes Measurement   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF SHEFFIELD   (United Kingdom)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ Bundesverband Prostatakrebs Selbsthilfe   (Germany)

^j Irish Cancer Society   (Ireland)

^k UNIVERSITY OF TEXAS   (United States)

^l UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^m MONASH UNIVERSITY   (Australia)

ⁿ LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^o UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^p UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^q BRIGHAM AND WOMEN S HOSPITAL   (United States)

^r UNIVERSITY OF FLORIDA   (United States)

^s REPATRIATION GENERAL HOSPITAL   (Australia)

^t SHEBA MEDICAL CENTER   (Israel)

^u Cancer Voices Australia   (Australia)

^v CEDARS SINAI MEDICAL CENTER   (United States)

^w NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^x MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^y MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^z UNIVERSITY HOSPITAL ULM   (Germany)

more..

Author keywords

Outcome measurement; Patient reported; Prostate cancer; Value

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; BRACHYTHERAPY; CAUSE SPECIFIC SURVIVAL; COMORBIDITY; CONSENSUS; DELPHI STUDY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MALE; METASTASIS FREE SURVIVAL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RADIATION ONCOLOGIST; STANDARD SET; STANDARDIZATION; TELECONFERENCE; URINE INCONTINENCE; UROLOGIST;

EID: 84961291675     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.08.075     Document Type: Article

References (26)

1. C.B. Begg, E.R. Riedel, and P.B. Bach Variations in morbidity after radical prostatectomy N Engl J Med 346 2002 1138 1144
2. A.B. Chen, A.V. D'Amico, B.A. Neville, E.W. Steyerberg, and C.C. Earle Provider case volume and outcomes following prostate brachytherapy J Urol 181 2009 113 118 discussion 118
3. P.L. Nguyen, X. Gu, and S.R. Lipsitz Cost implications of the rapid adoption of newer technologies for treating prostate cancer J Clin Oncol 29 2011 1517 1524
4. N.C. Sheets, G.H. Goldin, and A.M. Meyer Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer JAMA 307 2012 1611 1620
5. J.C. Hu, X. Gu, and S.R. Lipsitz Comparative effectiveness of minimally invasive vs open radical prostatectomy JAMA 302 2009 1557 1564
6. M.E. Porter, and E.O. Teisberg Redefining health care: creating value-based competition on results 2006 Harvard Business School Press Boston, MA
7. M.E. Porter What is value in health care? N Engl J Med 363 2010 2477 2481
8. S.B. Zeliadt, S.D. Ramsey, and D.F. Penson Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer Cancer 106 2006 1865 1874
9. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
10. J.A. Clark, and J.A. Talcott Symptom indexes to assess outcomes of treatment for early prostate cancer Med Care 39 2001 1118 1130
11. L. Ashley, H. Jones, and J. Thomas Integrating patient reported outcomes with clinical cancer registry data: a feasibility study of the electronic Patient-Reported Outcomes from Cancer Survivors (ePOCS) system J Med Internet Res 15 2013 e230
12. J.A. Talcott, J. Manola, and R.C. Chen Using patient-reported outcomes to assess and improve prostate cancer brachytherapy BJU Int 114 2014 511 516
13. A. Vickers, C. Savage, and F. Bianco Cancer control and functional outcomes after radical prostatectomy as markers of surgical quality: analysis of heterogeneity between surgeons at a single cancer center Eur Urol 59 2011 317 322
14. G.L. Andriole, E.D. Crawford, and R.L. Grubb III Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 2009 1310 1319
15. F.H. Schroder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
16. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
17. J.T. Wei, R.L. Dunn, M.S. Litwin, H.M. Sandler, and M.G. Sanda Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer Urology 56 2000 899 905
18. A.J. Vickers, C.J. Savage, M. Shouery, J.A. Eastham, P.T. Scardino, and E.M. Basch Validation study of a web-based assessment of functional recovery after radical prostatectomy Health Qual Life Outcomes 8 2010 82
19. J.J. Chipman, M.G. Sanda, and R.L. Dunn Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice J Urol 191 2014 638 645
20. G. van Andel, A. Bottomley, and S.D. Fossa An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer Eur J Cancer 44 2008 2418 2424
21. N.K. Aaronson, S. Ahmedzai, and B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
22. M.J. Resnick, T. Koyama, and K.H. Fan Long-term functional outcomes after treatment for localized prostate cancer N Engl J Med 368 2013 436 445
23. D. Sarfati Review of methods used to measure comorbidity in cancer populations: no gold standard exists J Clin Epidemiol 65 2012 924 933
24. S. Habbous, K.P. Chu, and L.T. Harland Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patients Oral Oncol 49 2013 407 412
25. R.A. Berenson, and D.R. Kaye Grading a physician's value-the misapplication of performance measurement N Engl J Med 369 2013 2079 2081
26. D.C. Miller, J.T. Wei, and R.L. Dunn Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference Urology 68 2006 166 171